Edap Tms (FOCL) EBT Margin (2009 - 2026)
Edap Tms' (FOCL) quarterly EBT Margin came in at 50.18% in Q1 2026, up 99.0% YoY from 25.22% in Q1 2025, and down 16.88% on a QoQ basis from 42.93% in Q4 2025.
Edap Tms (FOCL) EBT Margin (2009 - 2026) Analysis & Trends
Edap Tms (FOCL) has 18 years of EBT Margin data on file, last reported at 50.18% in Q1 2026.
- Quarterly EBT Margin rose 99.0% year-over-year to 50.18% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 40.89% (down 695.0% YoY) and the FY2025 annual result came in at 40.85%, down 1164.0% from the prior year.
- EBT Margin slipped to 50.18% in Q1 2026, from 42.93% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 13.8% in Q2 2022 to a low of 51.17% in Q1 2025.
- A 5-year average of 28.74% and a median of 34.02% in 2022 frame the typical range for EBT Margin.
- Annual changes were most pronounced in 2023 — EBT Margin tumbled 5363 bps — and 2024, when it jumped 2057 bps.
- Tracing FOCL's EBT Margin over 5 years: stood at 34.02% in 2022, then advanced by 29 bps to 24.02% in 2023, then jumped by 60 bps to 9.61% in 2024, then plunged by 347 bps to 42.93% in 2025, then decreased by 17 bps to 50.18% in 2026.
- The last three EBT Margin figures came in at 50.18% (Q1 2026), 42.93% (Q4 2025), and 35.39% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 100.02 Bn | 94.85 Bn | 3.69 Bn | 1.24% |
| 2 | Cencora | 60.88 Bn | 58.06 Bn | 3.61 Bn | 1.18% |
| 3 | Cardinal Health | 54.14 Bn | 49.29 Bn | 2.56 Bn | 0.87% |
| 4 | Henry Schein | 10.05 Bn | 9.90 Bn | 1.10 Bn | 3.96% |
| 5 | Akso Health | 737.16 Mn | 736.96 Mn | - | - |
| 6 | Edap Tms | 159.12 Mn | 137.58 Mn | 7.34 Mn | -109.10% |
| 7 | Accendra Health | 100.85 Mn | 93.20 Mn | 263.41 Mn | -14.29% |
| 8 | 111 | 32.10 Mn | -26.65 Mn | 18.18 Mn | -1.14% |
| 9 | Cosmos Health | 12.73 Mn | 10.29 Mn | 1.51 Mn | -32.06% |
| 10 | VitaNova Life Sciences | 11.51 Mn | 9.91 Mn | 264,662.00 | -5.99% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -50.18% |
| Dec 31, 2025 | -42.93% |
| Sep 30, 2025 | -35.39% |
| Jun 30, 2025 | -34.33% |
| Mar 31, 2025 | -51.17% |
| Dec 31, 2024 | -9.61% |
| Sep 30, 2024 | -48.38% |
| Jun 30, 2024 | -38.03% |
| Mar 31, 2024 | -29.75% |
| Dec 31, 2023 | -24.02% |
| Sep 30, 2023 | -33.24% |
| Jun 30, 2023 | -31.36% |
| Mar 31, 2023 | -50.32% |
| Dec 31, 2022 | -34.02% |
| Sep 30, 2022 | 7.09% |
| Jun 30, 2022 | 13.80% |
| Mar 31, 2022 | 3.30% |
| Dec 31, 2021 | 9.09% |
| Sep 30, 2021 | -9.58% |
| Jun 30, 2021 | -3.53% |